What Intelliseq does

Intelliseq is a computational genomics company founded in 2014 in Kraków, Poland, that builds cloud-based software for automated tertiary analysis and clinical interpretation of next-generation sequencing (NGS) data. Its core product is the iFlow platform — hosted on Google Cloud infrastructure — which automates the variant-prioritization, ACMG/AMP classification, and clinical-report-generation steps that traditionally require manual expert review. On top of iFlow sits the GeneSpect Reporter suite, comprising five specialized modules: Hereditary Reporter (rare disease), Somatic Reporter (oncology), PGx Reporter (pharmacogenomics, covering 200+ drugs), PRS Reporter (polygenic risk scoring for wellness and health traits), and Myeloid Plus Reporter (hematologic oncology). The platform is differentiated by proprietary algorithms — ExploRare and VarMatch for phenotype-driven variant prioritization, and the Intelliseq Polygenic algorithm for star-allele/diplotype calling — and by a compliance posture (EN ISO 13485, HIPAA, GDPR, IEEE 2791-2020, EMQN) that allows it to operate inside regulated clinical and reference-lab workflows.

Intelliseq sells primarily to clinical laboratories, genomics research institutions, health systems, CROs, and molecular-diagnostics kit manufacturers, using a sales-led GTM anchored by 'Book a Demo' CTAs, conference presence (ACMG, AACR, ASCO, ASHG, AMP), and an expanding US commercial team. Revenue mechanics are a mix of subscription/usage-based pricing on the iFlow platform (pay-per-analysis), custom workflow development as professional services, and channel distribution through technology integrations with DNAnexus (precision health data cloud, since January 2024) and Manifold (AI platform for life sciences, since 2025). Marquee customers and collaborators include Hospital for Special Surgery, University of Kentucky, Isfahan University of Medical Sciences, and Lankenau Institute for Medical Research. The company is privately held, backed by Vinci HiTech (lead investor in the March 2025 €4.5M round), Unfold.vc, European Medical Fund, YouNick Mint, and Venture INC ASI S.A., and operates a US subsidiary (Intelliseq C-corp) out of Murrieta, California, to support North American expansion.

Name

Intelliseq

Legal name

INTELLISEQ SA

Website

https://intelliseq.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Intelliseq provides a cloud-based platform (iFlow) and GeneSpect Reporter modules that automate tertiary analysis and clinical interpretation of NGS data for clinical labs, genomics research institutions, health systems, and diagnostics manufacturers.

Ownership category

akta.pro rank

Product category

Genomic Data Analysis Software

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182), Scientific Research and Development Services (5417), Medical Laboratories (621511)

SIC

Services-Prepackaged Software (7372), Services-Medical Laboratories (8071), Services-Computer Processing & Data Preparation (7374)

akta.pro primary industry

Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA)

akta.pro secondary industry

Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)

Keywords

• NGS data analysis
• Clinical genomic interpretation
• Pharmacogenomics reporting
• Polygenic risk scoring
• Bioinformatics software

Headquarters

HQ city

Kraków

HQ country

Poland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

1. iFlow Platform Subscription/Usage: Cloud-based SaaS platform for genomic data analysis. Pay-per-analysis pricing model for NGS data interpretation. Subscription-based access to GeneSpect Reporter suite including Hereditary, Somatic, PGx, and PRS modules.
2. Analysis Services: Per-analysis pricing for genomic interpretation workflows. Fast turnaround time from fastq file to final report in under 4 hours for PGx analysis. Cost-effectiveness through pay-per-analysis model.
3. Custom Workflow Development: Custom workflows developed upon request from Business Customers for specific analysis needs. Hosted on separate git repository with controlled access.

Pricing tiers

Go-to-market motion4 records

Distribution channels4 records

Marketing channels7 records

Core offering

Intelliseq provides a cloud-based iFlow platform for automated tertiary analysis of next-generation sequencing (NGS) data, delivering clinical interpretation of genomic data at scale. The platform hosts the GeneSpect suite of analysis modules covering hereditary disorders, somatic/oncology, pharmacogenomics (PGx), and polygenic risk scoring (PRS), enabling clinical labs, genomics labs, health systems, and CROs to convert raw sequencing data into standardized, clinically validated reports.

Product overview

Intelliseq offers a platform-plus-modules architecture centered on the iFlow cloud platform for automated genomic data analysis and interpretation. The GeneSpect suite of analysis modules includes five specialized reporters: GeneSpect Hereditary Reporter for hereditary disorders, GeneSpect Somatic Reporter for oncology applications, GeneSpect PGx Reporter for pharmacogenomics, GeneSpect PRS Reporter for polygenic risk scoring, and GeneSpect Myeloid Plus Reporter for myeloid cancer analysis. These modules share the iFlow platform infrastructure for workflow execution, data processing, and report generation, enabling researchers to design, execute, and customize pipelines across diverse areas of genomic research. The platform features automated ACMG/AMP classification, phenotype-driven variant prioritization using ExploRare and VarMatch algorithms, and standardized clinical report generation.

Differentiator

Problem solved

Functional benefit

Brands

• GeneSpect Reporter: Suite of analysis modules for genomic interpretation including Hereditary Reporter, Somatic Reporter, PGx Reporter, PRS Reporter, and Myeloid Plus Reporter.
• iFlow

Products and services

• iFlow Platform Cloud-based genomic data analysis and interpretation platform enabling flexible, scalable workflows for large-scale human genomics studies. Supports automated tertiary analysis, variant filtering, annotation, and clinical contextualization with standardized report generation. Targets clinical labs, genomics labs, and health systems.
• GeneSpect Hereditary Reporter Automated tertiary analysis solution for hereditary disorders that uncovers genetic disorders and inheritance patterns through accurate matching of genomic changes to patient phenotypic traits. Integrates phenotype-driven filtering using HPO terms, ACMG/AMP classification, and automated report generation.
• GeneSpect Somatic Reporter Oncology-focused interpretation solution that transforms genetic data into actionable insights for cancer patients. Provides automated somatic variant classification aligned with AMP/ACMG guidelines and generates standardized clinical reports for blood cancers and solid tumors.
• GeneSpect PGx Reporter Pharmacogenomics reporter providing comprehensive recommendations for personalized drug selection tailored to unique genotypes. Leverages proprietary Intelliseq Polygenic algorithm to identify star allele diplotypes and translate them into drug metabolism rates, covering over 200 drugs across pain management, psychiatry, and cardiovascular areas.
• GeneSpect PRS Reporter Polygenic Risk Score analysis tool for genome-wide assessment of genetic predisposition to wellness and health-related traits. Combines information on multiple genetic variants across the genome to determine relative risk and enable personalized medicine strategies.
• GeneSpect Myeloid Plus Reporter Specialized genomic reporter for myeloid cancer analysis and interpretation, designed for hematological malignancy workflows.

Quantifiable outcome

• 100% concordance with expert ACMG/AMP interpretation in hereditary hearing loss case study - no reclassification needed
• +3 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability3 records

Feature8 records

Partnerships

Six partnerships are on record, tiered core and minor.

• DNAnexus Inc.coreTechnology or Integration · 1 January 2024January 2024 partnership to integrate automated genomic variant interpretation into DNAnexus precision health data cloud platform. DNAnexus provides cloud-based genomics data platform; Intelliseq provides iFlow interpretation capabilities.
• ManifoldcoreStrategic or Co-development PartnerStrategic partnership integrating Intelliseq's iFlow platform and GeneSpect Reporters into Manifold's AI platform for life sciences. Enables automated transformation of raw sequencing data into structured, clinically meaningful outputs that are AI-ready. Manifold provides governed environment for multimodal data.
• Hospital for Special Surgery (HSS)coreStrategic or Co-development PartnerHSS, the world's leading academic medical center for musculoskeletal health, engaged Intelliseq for whole genome sequencing and bioinformatics services to study genetic factors influencing patient recovery following spine surgery, with focus on postoperative inflammatory risk.
• University of KentuckycoreStrategic or Co-development PartnerResearch collaboration in pilot study for hereditary hearing loss using iFlow automated tertiary analysis. University provided clinical samples and phenotypic data; Intelliseq performed WES tertiary analysis demonstrating 100% concordance with expert interpretation.
• Isfahan University of Medical SciencescoreStrategic or Co-development PartnerResearch collaboration in pilot study for hereditary hearing loss alongside University of Kentucky. Contributed clinical samples and phenotypic data for iFlow platform validation.
• Lankenau Institute for Medical Research (LIMR)minorStrategic or Co-development PartnerIntelliseq delivered talk on 'Genomic workflows: From variant calling to functional insights in cardiovascular applications' at LIMR. Collaboration focused on integrating computational interpretation with clinical application for cardiovascular patients.

Scale indicators4 records

Recent moves6 records

Expansion highlights7 records

Broad incumbents

• Roche: Roche offers the Navify digital health platform including Navify Mutation Profiler for oncology variant interpretation — a global diagnostics incumbent whose portfolio overlaps with Intelliseq's somatic oncology interpretation offering.
• Illumina: Illumina offers BaseSpace Sequence Hub and Illumina Connected Analytics plus the Variant Interpreter product for NGS tertiary analysis — a much larger incumbent with bundled hardware/software economics and broader portfolio, but overlapping capability with Intelliseq's iFlow interpretation layer.
• Agilent Technologies: Agilent offers the Cartagenia/Alissa Clinical Informatics platform for hereditary and somatic NGS variant interpretation — a broad life sciences instrumentation incumbent with an interpretation software suite that overlaps with Intelliseq's hereditary and somatic workflows.
• Tempus Labs: Tempus offers an AI-enabled precision medicine platform combining NGS testing, clinical data, and analytics — broader scope than Intelliseq but overlaps in oncology variant interpretation and clinical report generation for health systems.

Direct peers

• GenomOncology: GenomOncology provides NGS interpretation and clinical reporting software for oncology workflows including somatic and hereditary cancer panels — overlapping directly with Intelliseq's GeneSpect Somatic and Hereditary Reporters for clinical lab customers.
• Sophia Genetics: Sophia Genetics offers the SOPHiA DDM platform for clinical NGS data interpretation across hereditary, oncology, and pharmacogenomics — directly comparable to Intelliseq's iFlow + GeneSpect Reporter suite in target buyer (clinical labs), use cases, and product architecture.
• Molecular Health: Molecular Health offers MH Guide and related clinical genomics decision support software for variant interpretation across hereditary disease and oncology — directly comparable to Intelliseq's tertiary analysis platform for clinical labs and health systems.
• Velsera: Velsera (formed from merger of Seven Bridges, PierianDx, and UgenTec) provides clinical genomics interpretation platforms for hereditary, somatic, and pharmacogenomics workflows — directly overlapping with Intelliseq's tertiary analysis and clinical reporting offering for hospital and lab customers.

Emerging players

• Fabric Genomics: Fabric Genomics (formerly Omicia) provides AI-driven NGS interpretation for hereditary disease and rare disease diagnostics — comparable niche focus to Intelliseq's Hereditary Reporter and similar customer profile in clinical genetics labs.
• BC Platforms: BC Platforms provides genomic data management and interpretation infrastructure for research, clinical, and pharma customers — comparable in scale and stage to Intelliseq with partial overlap on tertiary analysis and pharmacogenomics use cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks4 records

Key highlights7 records

Customer concentration

• Xx.com/intelliseq
• Facebookfacebook.com/Intelliseq
• LinkedInlinkedin.com/company/intelliseq

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds4 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Intelliseq